SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Phillips, T. R.
Right arrow Articles by Henriksen, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Phillips, T. R.
Right arrow Articles by Henriksen, S. J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Methamphetamine and HIV-1: potential interactions and the use of the FIV/cat model

T. R. Phillips

The Scripps Research Institute, Department of Neuropharmacology, Cal-4, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA; tphillips{at}scripps.edu

J. N. Billaud

S. J. Henriksen

Department of Neuropharmacology, The Scripps Research Institute, La Jolla, CA, USA

The interaction of methamphetamine with human immunodeficiency virus (HIV), the aetiologic agent of Acquired Immune Deficiency Syndrome (AIDS), has not been thoroughly investigated. However, increasingly, a larger proportion of HIV infected individuals acquire the virus through methamphetamine use or are exposed to this drug during their disease course. In certain populations, there is a convergence of methamphetamine use and HIV-1 infection; yet our understanding of the potential effects that simultaneous exposure to these two agents have on disease progression is extremely limited. Studying the interactions between methamphetamine and lentivirus in people is difficult. To thoroughly understand methamphetamine's effects on lentivirus disease progression, an animal model that is both clinically relevant and easily manipulated is essential. In this report, we identified potential problems with methamphetamine abuse in individuals with a concurrent HIV-1 infection, described the Feline Immunodeficiency Virus (FIV)/cat model for HIV-1, and reported our early findings using this modelling system to study the interaction of methamphetamine and lentivirus infections.

Key Words: AIDS • FIV • HIV • methamphetamine

Journal of Psychopharmacology, Vol. 14, No. 3, 244-250 (2000)
DOI: 10.1177/026988110001400309
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
R. Potula and Y. Persidsky
Adding Fuel to the Fire: Methamphetamine Enhances HIV Infection
Am. J. Pathol., June 1, 2008; 172(6): 1467 - 1470.
[Abstract] [Full Text] [PDF]

Home page
 AIDS Clin CareHome page
Crystal Meth and HIV/AIDS: The Perfect Storm?
AIDS Clinical Care, December 3, 2007; 2007(1203): 1 - 1.
[Full Text]

Home page
 Clin. Microbiol. Rev.Home page
S. VandeWoude and C. Apetrei
Going Wild: Lessons from Naturally Occurring T-Lymphotropic Lentiviruses
Clin. Microbiol. Rev., October 1, 2006; 19(4): 728 - 762.
[Abstract] [Full Text] [PDF]


Advertisement